Articles by Cristina Nanni

Pretherapeutic Dosimetry in Patients Affected by Metastatic Thyroid Cancer Using 124I PET/CT Sequential Scans for 131I Treatment Planning

Pettinato, Cinzia; Spezi, Emiliano; Nanni, Cristina; More

Clinical Nuclear Medicine. 39(8):e367-e374, August 2014.

The Role of 11C-Choline PET Imaging in the Early Detection of Recurrence in Surgically Treated Prostate Cancer Patients With Very Low PSA Level <0.5 ng/mL

Mamede, Marcelo; Ceci, Francesco; Castellucci, Paolo; More

Clinical Nuclear Medicine. 38(9):e342-e345, September 2013.

The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients

Nanni, Cristina; Zamagni, Elena; Celli, Monica; More

Clinical Nuclear Medicine. 38(2):e74-e79, February 2013.

When Should F-18 FDG PET/CT Be Used Instead of 68Ga-DOTA-Peptides to Investigate Metastatic Neuroendocrine Tumors?

Fuccio, Chiara; Musto, Alessandra; Cambioli, Silvia; More

Clinical Nuclear Medicine. 36(12):1109-1111, December 2011.

Somatostatin Receptor Scintigraphy for Bronchial Carcinoid Follow-Up

FANTI, STEFANO; FARSAD, MOHSEN; BATTISTA, GIUSEPPE; More

Clinical Nuclear Medicine. 28(7):548-552, July 2003.